12/19
11:06 pm
rgen
Repligen Co. (NASDAQ: RGEN) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Repligen Co. (NASDAQ: RGEN) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
12/17
09:12 am
rgen
Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "hold" rating and a $165.00 price target on the stock.
Low
Report
Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "hold" rating and a $165.00 price target on the stock.
12/17
09:04 am
rgen
Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "hold" rating and a $165.00 price target on the stock.
Low
Report
Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "hold" rating and a $165.00 price target on the stock.
12/12
12:42 pm
rgen
Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Low
Report
Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
12/12
07:36 am
rgen
Repligen Announces Publication of the Company's 2023 Corporate Sustainability Report [Yahoo! Finance]
Low
Report
Repligen Announces Publication of the Company's 2023 Corporate Sustainability Report [Yahoo! Finance]
12/12
07:30 am
rgen
Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report
Low
Report
Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report
12/9
07:42 am
rgen
Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns [Yahoo! Finance]
Medium
Report
Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns [Yahoo! Finance]
12/9
07:30 am
rgen
Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns
Medium
Report
Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns
11/23
12:31 am
rgen
Repligen Co. (NASDAQ: RGEN) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Repligen Co. (NASDAQ: RGEN) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
11/14
08:09 am
rgen
Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Medium
Report
Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
11/14
12:01 am
rgen
Repligen Co. (NASDAQ: RGEN) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Repligen Co. (NASDAQ: RGEN) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
11/13
06:22 am
rgen
Company News for Nov 13, 2024 [Yahoo! Finance]
Low
Report
Company News for Nov 13, 2024 [Yahoo! Finance]
11/13
02:12 am
rgen
Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
Medium
Report
Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
11/12
03:04 pm
rgen
Repligen Beats on Q3 Earnings & Sales, Narrows '24 Sales View [Yahoo! Finance]
Low
Report
Repligen Beats on Q3 Earnings & Sales, Narrows '24 Sales View [Yahoo! Finance]
11/12
12:12 pm
rgen
Repligen Stock Soars 10% on Record Growth and Bold Moves [Yahoo! Finance]
Low
Report
Repligen Stock Soars 10% on Record Growth and Bold Moves [Yahoo! Finance]
11/12
07:30 am
rgen
Repligen Reports Third Quarter 2024 Financial Results
Low
Report
Repligen Reports Third Quarter 2024 Financial Results
11/5
07:30 am
rgen
Repligen Corporation to Present at Upcoming Investor Conferences
Medium
Report
Repligen Corporation to Present at Upcoming Investor Conferences
10/31
07:30 am
rgen
Repligen to Report Third Quarter 2024 Financial Results
Low
Report
Repligen to Report Third Quarter 2024 Financial Results
10/22
11:53 am
rgen
Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release [Yahoo! Finance]
Low
Report
Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release [Yahoo! Finance]
10/14
11:28 am
rgen
Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More [Yahoo! Finance]
Low
Report
Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More [Yahoo! Finance]
9/26
11:04 am
rgen
Repligen Co. (NASDAQ: RGEN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $205.00 price target on the stock.
Low
Report
Repligen Co. (NASDAQ: RGEN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $205.00 price target on the stock.
9/24
07:30 am
rgen
Repligen Opens Training & Innovation Center to Elevate Customer Experience
Low
Report
Repligen Opens Training & Innovation Center to Elevate Customer Experience